Here are 19 key notes on orthopedic and spine device companies over the past week.
Surgeons have implanted more than 1,000 of Aurora Spine's ZIP MIS Interspinous Fusion Devices in patients, globally.
Recent clinical studies in Europe examining the AxioMed Freedom total disc replacement technology show favorable results.
Houston Methodist Hospital is the first in Houston to implement Blue Belt Technologies' Navio Surgical System with advanced CT-free intraoperative planning and navigation.
DFine commercially launched its Long SpineSTAR Ablation device.
Exactech Director James G. Binch sold 1,500 shares of the company's stock on Dec. 10.
Integra Lifesciences shares have increased by 1.40 percent in the last 20 days.
K2M Group Holdings received FDA clearance to market its EVEREST Minimally Invasive XT Spinal System.
Lima Corporate completed the acquisition of Zimmer Biomet's Zimmer Unicompartmental High Flex Knee and Discovery Elbow System for the Japanese market.
Zacks upgraded Mazor Robotics to a "buy" rating.
Medtronic and Samsung Electronics America are forming a broad-based strategic alliance to accelerate the development of digital health solutions.
Medtronic's board of directors approved a cash dividend of $0.38 per ordinary share for the third quarter of 2016.
Medtronic will open a new manufacturing facility in Galway, Ireland, to manufacture the IN.PACT Admiral drug-coated balloon to treat peripheral artery disease.
NeuroMetrix, a wearable medical technology developer, expanded distribution of its Quell Wearable Pain Relief device to The Grommet, an online product platform.
Bank of America upgraded NuVasive shares from an "underperform" rating on Dec. 11.
NuVasive company shares dropped .39 percent from Dec. 7 through Dec. 11.
OrthoSensor raised $3.9 million in a new financing round.
Stryker shares have been lowered from a 'market perform' rating to an 'underperform' rating by BMO Capital Markets.
Zimmer Biomet reported a quarterly dividend of $0.22 per share for the fourth quarter of 2015.
Zimmer Biomet is one of the three most expensive stocks in the market right now.